Motley Fool Staff

Need some help figuring out how to look at the market in this brand-new year? We got you.

Weight loss drugs are taking center spotlight, but other developing treatments could change how we live.

And we chat trends with Dave Holeman, CEO of Whitestone REIT.

We've also got a look at two stocks worth watching: Despegar and On Holding.

And we've got a look at a "snap test" for helping judge a company's competitive advantage.

We also talk about what's going on with Boeing.

These investors have a lot to talk about. And Burford Capital CEO Chris Bogart drops in to talk about the world of legal financing, his company's competitive advantages, and a high-stakes case with Argentina.

New year, new you! Or maybe just a new portfolio.

We've also got a look at two stocks worth watching: UiPath and Pebblebrook Hotel Trust.

ChatGPT in your car. Really?

Let's say you have a big goal for 2024, financially or personally. What happens after you reach it?

A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.

"The lessons we really learn, and earn, are a consequence of observing and living through history measured in years, not hours or days," Motley Fool co-founder David Gardner.

We've also got an investor's look at Aritzia and Shopify.

We've also got an investor's look at Duolingo and Spotify.

We've also got some productivity tips for the new year.

Motley Fool co-founder David Gardner responds to comments and questions from "Rule Breaker Investing" listeners.

We've also got Motley Fool co-founder Tom Gardner sharing an investing lesson from last year and a stock for this one.

There's still time to get yourself a holiday gift.

And a look toward 2024, too! There are still bright spots in real estate markets.